BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22962393)

  • 1. Complicated appearance of an abdominal mass in the I-131 MIBG and Tc-99m bone scintigraphy of a patient with neuroblastoma.
    Koç ZP; Karayalcin B
    BMJ Case Rep; 2012 Sep; 2012():. PubMed ID: 22962393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroblastoma: imaging evaluation by sequential Tc-99m MDP, I-131 MIBG, and Ga-67 citrate studies.
    Garty I; Friedman A; Sandler MP; Kedar A
    Clin Nucl Med; 1989 Jul; 14(7):515-22. PubMed ID: 2766633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the utility of
    Gauguet JM; Pace-Emerson T; Grant FD; Shusterman S; DuBois SG; Frazier AL; Voss SD
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28449267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodine-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma.
    Shulkin BL; Shapiro B; Hutchinson RJ
    J Nucl Med; 1992 Oct; 33(10):1735-40. PubMed ID: 1403138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A follow-up study using iodine-131 metaiodobenzylguanidine imaging in a patient with neuroblastoma.
    Ikekubo K; Habuchi Y; Jeong S; Yamaguchi H; Saiki Y; Ito H; Hino M; Higa T
    Clin Nucl Med; 1986 Nov; 11(11):777-80. PubMed ID: 3791787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of metaiodobenzylguanidine as a scintigraphic agent for the detection of neuroblastoma.
    Parisi MT; Greene MK; Dykes TM; Moraldo TV; Sandler ED; Hattner RS
    Invest Radiol; 1992 Oct; 27(10):768-73. PubMed ID: 1399431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intense uptake of 99mTc-MDP in primary abdominal neuroblastoma].
    Panoutsopoulos G; Ilias I; Parcharidou A; Christakopoulou I
    Rev Esp Med Nucl; 2002 Jul; 21(4):294-5. PubMed ID: 12206743
    [No Abstract]   [Full Text] [Related]  

  • 8. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
    Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans.
    Gordon I; Peters AM; Gutman A; Morony S; Dicks-Mireaux C; Pritchard J
    J Nucl Med; 1990 Feb; 31(2):129-34. PubMed ID: 2313350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The place of 99mTc-MDP skeletal scintigraphy in neuroblastoma. Is a new assessment necessary?].
    Sautter-Bihl ML; Bihl H; Heinze HG
    Nuklearmedizin; 1991 Feb; 30(1):7-12. PubMed ID: 2062676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 131I-MIBG in the diagnosis of primary and metastatic neuroblastoma.
    El-Maghraby T
    Gulf J Oncolog; 2007 Jul; (2):33-41. PubMed ID: 20084722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pitfalls in the diagnosis of neuroblastoma by 99mTc-MDP scintigraphy: a case report.
    Garty I; Siplovich L; Moguilner J
    Eur J Nucl Med; 1984; 9(12):564-5. PubMed ID: 6241151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of 99Tcm-sestamibi scintigraphy in the staging and prediction of the therapeutic response of stage IV neuroblastoma: comparison with 131I-MIBG and 99Tcm-MDP scintigraphy.
    Burak Z; Yüksel DA; Cetingül N; Kantar M; Ozkiliç H; Moretti JL
    Nucl Med Commun; 1999 Nov; 20(11):991-1000. PubMed ID: 10572908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Scintigraphic diagnosis of neuroblastoma using meta-iodobenzylguanidine].
    Kimmig B; Brandeis WE; Eisenhut M; Ludwig R; Adolph J
    Klin Padiatr; 1986; 198(3):224-9. PubMed ID: 3723986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of stage 4 neuroblastoma patients by means of MIBG and 99mTc-MDP scintigraphy.
    Turba E; Fagioli G; Mancini AF; Rosito P; Galli A; Alvisi P
    J Nucl Biol Med (1991); 1993 Sep; 37(3):107-14. PubMed ID: 8218456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases].
    Lumbroso J; Guermazi F; Hartmann O; Coornaert S; Rabarison Y; Lemerle J; Parmentier C
    Bull Cancer; 1988; 75(1):97-106. PubMed ID: 3359060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual Tc-99m MDP and I-123 MIBG images in focal pyelonephritis.
    Jacobs A; Lenoir P; Delree M; Ramet J; Piepsz A
    Clin Nucl Med; 1990 Nov; 15(11):821-4. PubMed ID: 2292157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Utility of the scintigraphy with (123)I MIBG in the diagnosis of neuroblastoma bone metastasis].
    Mena Bares LM; Benítez Velazco A; Pérez Cuenca E; Maza Muret FR; Hidalgo Ramos FJ; Pacheco Capote C; Contreras Puertas PI; Latre Romero JM
    Rev Esp Med Nucl; 2009; 28(4):208-9. PubMed ID: 19922836
    [No Abstract]   [Full Text] [Related]  

  • 19. Does I-131-MIBG underestimate skeletal disease burden in neuroblastoma?
    Barai S; Bandopadhayaya GP; Malhotra A; Agarwal S; Kumar R; Dhanapathi H
    J Postgrad Med; 2004; 50(4):257-60; discussion 260-1. PubMed ID: 15623965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [131I-MIBG scintigraphy for the detection of metastatic lesions from malignant pheochromocytoma--comparison of 131I-MIBG scintigraphy with 99mTc-MDP bone scintigraphy in detecting bone metastases].
    Ozawa N; Imaeda T; Seki M; Koike S
    Kaku Igaku; 1988 Jan; 25(1):97-103. PubMed ID: 3373813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.